Tübingen, Germany

Michael Sonntag

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 8.8

ph-index = 6

Forward Citations = 149(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by Michael Sonntag: A Pioneer in Long-Chain RNA Technology

Introduction

Michael Sonntag, an inventive mind located in Tübingen, Germany, has carved a niche for himself in the field of biotechnology, particularly through his significant contributions to long-chain RNA technology. With a remarkable portfolio comprising nine patents, Sonntag's work is paving the way for future advancements in pharmaceuticals and vaccines.

Latest Patents

Among his latest innovations is a patented dry powder composition that includes a storage-stable formulation of long-chain RNA. This groundbreaking invention focuses not only on the creation of a dry powder formulation through methods such as spray-drying and spray-freeze drying but also extends to its applications in pharmaceutical compositions and vaccines. The formulations aim to treat or prevent disorders and diseases, showcasing versatility and potential for impactful medical usage. Additionally, Sonntag’s patent covers kits of parts that incorporate this dry powder composition, further simplifying the implementation of his innovative solutions in various medical contexts.

Career Highlights

Michael Sonntag has significantly impacted the field of biotechnology through his work at prominent companies, namely Curevac AG and Curevac SE. His experience in these organizations has bolstered his understanding and expertise in developing RNA-based technologies that can be pivotal for future medical treatments. His portfolio reflects a commitment to innovation, particularly in a rapidly evolving industry.

Collaborations

Throughout his career, Sonntag has collaborated with notable professionals, including Fabian Johannes Eber and Thorsten Mutzke. These partnerships have undoubtedly enhanced his research and development efforts, bringing together diverse expertise to further advance the biotechnology landscape.

Conclusion

Michael Sonntag stands out as a leading inventor in long-chain RNA technology, with a diverse array of patents that promise to improve therapeutic approaches for various diseases. As he continues his work in the field, Sonntag's contributions are likely to shape the future of pharmaceutical innovations and pave the way for new medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…